Aurora Cannabis (XBUL:21P) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XBUL:21P Aurora Cannabis Inc XBUL:21P
52 GF Score
Price €2.43
GF Value €3.68
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Aurora Cannabis Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

XBUL:21P
52GF Score
Aurora Cannabis Inc XBUL:21P
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Aurora Cannabis (XBUL:21P) Overvalued in 2026?

Based on GuruFocus' analysis, Aurora Cannabis stock appears to be undervalued. The current stock price of €2.43 is trading 34% below its estimated GF Value™ of €3.68. GuruFocus considers Aurora Cannabis to be Possible Value Trap.

Key valuation signals for XBUL:21P:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €3.68 vs. price of €2.43 (34% below fair value)
  • GF Score™: 52/100 with 3 warning signs

No single metric tells the full story. See the XBUL:21P stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aurora Cannabis Business Description

Address 90B Street SW, Suite 2207, Edmonton, AB, CAN, T6X 1V8
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.
52GF Score

Get the complete analysis for XBUL:21P

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.43
Price
€3.68
GF Value